<DOC>
	<DOCNO>NCT02522754</DOCNO>
	<brief_summary>A study compare multiple dosage regime protesomal intranasal vaccine .</brief_summary>
	<brief_title>Development Intranasal Proteosome Influenza Vaccine</brief_title>
	<detailed_description>A Proteosome-adjuvanted trivalent inactivate influenza vaccine ( P-TIV ) administer intra-nasally show effective , safe , well tolerate , immunogenic - systemic mucosal compartment - effective preventing influenza illness . In two separate study use Human Viral Challenge Model , subject select susceptibility A/Panama/2007/1999 ( H3N2 ) virus dose one three regimen : ( A/New Caledonia/20/1999 ( H1N1 ) , A/Panama/2007/1999 ( H3N2 ) , B/Victoria/504/2000 B/Shangdong/7/1997 ) placebo via nasal spray . One two dos give , 14 day apart , subject challenge ~8.5 x 105 EID¬50 A/Panama/2007/1999 ( H3N2 ) virus . Immune responses vaccine antigen measure , namely serum IgG ( via aemagglutination inhibition assay ( HAI ) ) nasal wash secretory IgA ( sIgA ) antibody ( via ELISA ) . Viral titre nasal wash symptom influenza illness assess viral challenge compare .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Young healthy adult determine medical history , physical examination , serology ( HIV Hepatitis B C ) clinical laboratory test . Female subject require provide history reliable contraceptive practice . Susceptibility A/Panama/2007/1999 ( H3N2 ) ( serum reciprocal HAI titre ≤10 ) confirm screen . include ; asthma , hypersensitivity mercurials chicken egg , anatomic neurologic abnormality impair gag reflex contribute aspiration , * chronic nasopharyngeal complaint , abnormal electrocardiogram ( ECG ) , febrile illness significant symptom upper respiratory infection day vaccination admission quarantine administration challenge inoculum . Subjects use medication product rhinitis nasal congestion , Subject receive systemic glucocorticoid within 1 month , cytotoxic immunosuppressive drug within 6 month study start . Subjects agree smoke quarantine phase .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>